Equities research analysts predict that Exponent, Inc. (NASDAQ:EXPO) will post $78.74 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Exponent’s earnings, with the lowest sales estimate coming in at $77.38 million and the highest estimate coming in at $80.10 million. Exponent posted sales of $74.16 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 6.2%. The company is scheduled to announce its next quarterly earnings results on Wednesday, October 18th.

On average, analysts expect that Exponent will report full year sales of $78.74 million for the current year. For the next financial year, analysts anticipate that the company will report sales of $328.96 million per share, with estimates ranging from $320.12 million to $337.80 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Exponent.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Tuesday, July 18th. The business services provider reported $0.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.10. Exponent had a return on equity of 19.27% and a net margin of 15.70%. The firm had revenue of $84.10 million during the quarter, compared to analyst estimates of $79.30 million. During the same period last year, the company posted $0.38 EPS. The business’s quarterly revenue was up 14.7% on a year-over-year basis.

A number of analysts have recently weighed in on EXPO shares. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $74.00 target price for the company in a report on Thursday, July 20th. Cantor Fitzgerald reiterated a “buy” rating and set a $75.00 target price on shares of Exponent in a report on Thursday, August 31st. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a report on Thursday, July 20th. Finally, BidaskClub lowered shares of Exponent from a “sell” rating to a “strong sell” rating in a report on Tuesday, June 27th.

Exponent (NASDAQ EXPO) opened at 69.15 on Friday. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of 35.85 and a beta of 0.62. Exponent has a 52-week low of $48.42 and a 52-week high of $69.95. The stock has a 50 day moving average price of $65.96 and a 200 day moving average price of $61.03.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 22nd. Stockholders of record on Friday, September 1st will be issued a dividend of $0.21 per share. The ex-dividend date is Wednesday, August 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.21%. Exponent’s dividend payout ratio is currently 43.52%.

TRADEMARK VIOLATION WARNING: “$78.74 Million in Sales Expected for Exponent, Inc. (EXPO) This Quarter” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/09/10/78-74-million-in-sales-expected-for-exponent-inc-expo-this-quarter-2.html.

In related news, CEO Paul R. Johnston sold 4,000 shares of the stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $67.74, for a total value of $270,960.00. Following the completion of the transaction, the chief executive officer now directly owns 53,240 shares of the company’s stock, valued at $3,606,477.60. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Paul R. Johnston sold 4,095 shares of the stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $65.84, for a total transaction of $269,614.80. Following the completion of the transaction, the chief executive officer now directly owns 57,240 shares of the company’s stock, valued at $3,768,681.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 59,950 shares of company stock valued at $3,933,076. 2.80% of the stock is owned by insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. raised its stake in Exponent by 41,234.4% in the first quarter. BlackRock Inc. now owns 3,080,242 shares of the business services provider’s stock worth $183,428,000 after buying an additional 3,072,790 shares in the last quarter. Vanguard Group Inc. raised its stake in Exponent by 3.9% in the second quarter. Vanguard Group Inc. now owns 2,261,432 shares of the business services provider’s stock worth $131,841,000 after buying an additional 85,291 shares in the last quarter. TimesSquare Capital Management LLC raised its stake in Exponent by 1.3% in the first quarter. TimesSquare Capital Management LLC now owns 876,650 shares of the business services provider’s stock worth $52,205,000 after buying an additional 11,650 shares in the last quarter. Conestoga Capital Advisors LLC raised its stake in Exponent by 15.6% in the second quarter. Conestoga Capital Advisors LLC now owns 727,177 shares of the business services provider’s stock worth $42,394,000 after buying an additional 98,280 shares in the last quarter. Finally, State Street Corp raised its stake in Exponent by 4.5% in the second quarter. State Street Corp now owns 642,196 shares of the business services provider’s stock worth $37,436,000 after buying an additional 27,930 shares in the last quarter. 88.26% of the stock is owned by institutional investors.

About Exponent

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.